MRSA Research - Methicillin-Resistant Staphylococcus Aureus, Hospitals, Infection, Antibiotic Resistance, Superbugs

MRSA Research Today is a free monthly online journal that collates and summarizes the latest research about MRSA, including details on methicillin-resistant staphylococcus aureus, hospitals, infection, antibiotic resistance, superbugs.


MRSA Research Today

Home

View Latest Issue

Information About MRSA

Books on MRSA

Advertising in Research Today

View Other Research Today Publications



Volume 4 (2007), Issue 7 (July)

  1. Cross-infection in cystic fibrosis: The knowledge and behaviour of adult patients.
    J Cyst Fibros, 6(4): 262-6. [Abstract] [Full-text]
  2. Therapeutic applications of tigecycline in the management of complicated skin and skin structure infections.
    Int J Infect Dis, 11: S7-15. [Abstract] [Full-text]
  3. Surgical site and vascular infections: treatment and prophylaxis.
    Int J Infect Dis, 11: S17-22. [Abstract] [Full-text]
  4. Impact of infection control interventions and antibiotic use on hospital MRSA: a multivariate interrupted time-series analysis.
    Int J Antimicrob Agents, 30(2): 169-76. [Abstract] [Full-text]
  5. Evaluation of the IDI-MRSA assay on the SmartCycler real-time PCR platform for rapid detection of MRSA from screening specimens.
    Eur J Clin Microbiol Infect Dis, 26(7): 459-466. [Abstract] [Full-text]
  6. Synthesis and antimicrobial evaluation of water-soluble, dendritic derivatives of epimeric 5alpha-cholestan-3-amines and 5alpha-cholestan-3-yl aminoethanoates.
    Steroids, 72(8): 615-26. [Abstract] [Full-text]
  7. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
    Int J Antimicrob Agents, 30(2): 143-9. [Abstract] [Full-text]
  8. Characterization of macrolide resistance in Gram-positive cocci from Colombian hospitals: a countrywide surveillance.
    Int J Infect Dis, 11(4): 329-36. [Abstract] [Full-text]
  9. In Vivo Efficacy of a Novel Oxazolidinone Compound in Two Mouse Models of Infection.
    Antimicrob Agents Chemother. [Abstract] [Full-text]
  10. Selective application of sartorius muscle flaps and aggressive staged surgical debridement can influence long-term outcomes of complex prosthetic graft infections.
    J Vasc Surg, 46(1): 71-8. [Abstract] [Full-text]
  11. Shared functional attributes between the mecA gene product of Staphylococcus sciuri and penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus.
    Biochemistry, 46(27): 8050-7. [Abstract] [Full-text]
  12. Nasal carriage of a single clone of community-acquired methicillin-resistant Staphylococcus aureus among kindergarten attendees in northern Taiwan.
    BMC Infect Dis, 7: 51. [Abstract] [Full-text]
  13. MRSA-related perianal abscesses: an underrecognized disease entity.
    Dis Colon Rectum, 50(7): 996-1003. [Abstract] [Full-text]
  14. Comparison of Two Versions of the IDI-MRSA Assay Using Charcoal Swabs for Prospective Nasal and Nonnasal Surveillance Samples.
    J Clin Microbiol, 45(7): 2278-80. [Abstract] [Full-text]
  15. Clinical Validation of the Molecular BD GeneOhm StaphSR Assay for Direct Detection of Staphylococcus aureus and Methicillin-Resistant Staphylococcus aureus in Positive Blood Cultures.
    J Clin Microbiol, 45(7): 2191-6. [Abstract] [Full-text]
  16. Phenotypic Prediction Rule for Community-Associated Methicillin-Resistant Staphylococcus aureus.
    J Clin Microbiol, 45(7): 2293-5. [Abstract] [Full-text]
  17. Multiple-Locus Variable-Number Tandem-Repeat Assay Analysis of Methicillin-Resistant Staphylococcus aureus Strains.
    J Clin Microbiol, 45(7): 2215-9. [Abstract] [Full-text]
  18. Use of CultureSwab Plus Swabs with Amies Gel Agar for Testing of Naris Specimens with the GeneOhm MRSA Assay.
    J Clin Microbiol, 45(7): 2281-3. [Abstract] [Full-text]
  19. Vascular graft infection by Staphylococcus aureus: efficacy of cefazolin, teicoplanin and vancomycin prophylaxis protocols in a rat model.
    Eur J Vasc Endovasc Surg, 34(2): 182-7. [Abstract] [Full-text]
  20. Distribution of capsular and surface polysaccharide serotypes of Staphylococcus aureus.
    Diagn Microbiol Infect Dis, 58(3): 297-302. [Abstract] [Full-text]
  21. In vitro activity of ceftobiprole, daptomycin, linezolid, and vancomycin against methicillin-resistant staphylococci associated with endocarditis and bone and joint infection.
    Diagn Microbiol Infect Dis, 58(3): 363-5. [Abstract] [Full-text]
  22. Evaluation of real-time polymerase chain reaction for the detection of methicillin-resistant Staphylococcus aureus on environmental surfaces.
    Infect Control Hosp Epidemiol, 28(8): 1003-5. [Abstract] [Full-text]
  23. Methicillin-resistant Staphylococcus aureus: a 5-year review of surveillance data in a tertiary care hospital in Saudi Arabia.
    Infect Control Hosp Epidemiol, 28(8): 976-82. [Abstract] [Full-text]
  24. Successful control of widespread methicillin-resistant Staphylococcus aureus colonization and infection in a large teaching hospital in the Netherlands.
    Infect Control Hosp Epidemiol, 28(8): 970-5. [Abstract] [Full-text]
  25. Prevalence of nasal colonization among patients with community-associated methicillin-resistant Staphylococcus aureus infection and their household contacts.
    Infect Control Hosp Epidemiol, 28(8): 966-9. [Abstract] [Full-text]
  26. Synthesis, characterisation and antimicrobial activity of copper(II) and manganese(II) complexes of coumarin-6,7-dioxyacetic acid (cdoaH(2)) and 4-methylcoumarin-6,7-dioxyacetic acid (4-MecdoaH(2)): X-ray crystal structures of [Cu(cdoa)(phen)(2)].8.8H(2)O and [Cu(4-Mecdoa)(phen)(2)].13H(2)O (phen=1,10-phenanthroline).
    J Inorg Biochem, 101(8): 1108-19. [Abstract] [Full-text]
  27. Comparative activity of telavancin against isolates of community-associated methicillin-resistant Staphylococcus aureus.
    J Antimicrob Chemother, 60(2): 406-9. [Abstract] [Full-text]
  28. Three novel highly charged copper-based biocides: safety and efficacy against healthcare-associated organisms.
    J Antimicrob Chemother, 60(2): 294-9. [Abstract] [Full-text]
  29. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
    J Antimicrob Chemother, 60(2): 300-11. [Abstract] [Full-text]
  30. The UK Vascular Access Survey Follow-up data and repeat survey (Chapter 5).
    Nephrol Dial Transplant. [Abstract] [Full-text]
  31. Low antibiotic resistance rates in Staphylococcus aureus, Escherichia coli and Klebsiella spp but not in Enterobacter spp and Pseudomonas aeruginosa: a prospective observational study in 14 Swedish ICUs over a 5-year period.
    Acta Anaesthesiol Scand, 51(7): 937-41. [Abstract] [Full-text]
  32. Patient perceptions of osteomyelitis, septic arthritis and prosthetic joint infection: the psychological influence of methicillin-resistant Staphylococcus aureus.
    Intern Med J, 37(8): 536-42. [Abstract] [Full-text]
  33. Variability in SCCmecN1 spreading among injection drug users in Zurich, Switzerland.
    BMC Microbiol, 7: 62. [Abstract] [Full-text]
  34. Investigation of meticillin-resistant Staphylococcus aureus in pigs used for research.
    J Med Microbiol, 56: 1107-9. [Abstract] [Full-text]
  35. Management of ventilator-associated pneumonia in a multidisciplinary intensive care unit: does trauma make a difference?
    Intensive Care Med, 33(8): 1387-1395. [Abstract] [Full-text]
  36. Observations on vancomycin use in U.S. hospitals.
    Am J Health Syst Pharm, 64(15): 1633-41. [Abstract] [Full-text]
  37. Evaluation of biofilm production and prevalence of the icaD gene in methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains isolated from patients with nosocomial infections and carriers.
    FEMS Immunol Med Microbiol, 50(3): 375-9. [Abstract] [Full-text]
  38. Sodium fusidate-poly(D,L-lactide-co-glycolide) microspheres: preparation, characterisation and in vivo evaluation of their effectiveness in the treatment of chronic osteomyelitis.
    J Microencapsul, 24(6): 577-95. [Abstract] [Full-text]
  39. A novel approach to reduce catheter-related infection using sustained-release basic fibroblast growth factor for tissue regeneration in mice.
    Heart Vessels, 22(4): 261-7. [Abstract] [Full-text]
  40. Screening of plant extracts for antimicrobial activity against bacteria and yeasts with dermatological relevance.
    Phytomedicine, 14(7): 508-16. [Abstract] [Full-text]
  41. Synthesis and antimicrobial activity of some new thiazolyl thiazolidine-2,4-dione derivatives.
    Bioorg Med Chem, 15(18): 6012-7. [Abstract] [Full-text]
  42. Molecular design of anti-MRSA agents based on the anacardic acid scaffold.
    Bioorg Med Chem, 15(18): 6236-41. [Abstract] [Full-text]
  43. Community-associated methicillin-resistant Staphylococcus aureus prevalence: How common is it? A methodological comparison of prevalence ascertainment.
    Am J Infect Control, 35(6): 359-66. [Abstract] [Full-text]
  44. Spectrum of eye disease caused by methicillin-resistant Staphylococcus aureus.
    Am J Ophthalmol, 144(2): 313-5. [Abstract] [Full-text]
  45. Infectious complications and managements for surgical site infections in genital Paget's disease.
    J Eur Acad Dermatol Venereol, 21(7): 897-901. [Abstract] [Full-text]
Place a permanent text-link or advertisement here for just US$15.

© 2004-2008 MRSA Research Today. All Rights Reserved.



MRSA Research Today Archive:

Volume 1 (2004)
  Issue 1 (October)
  Issue 2 (November)
  Issue 3 (December)

Volume 2 (2005)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 3 (2006)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 4 (2007)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 5 (2008)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)



MRSA Books

Viruses vs. Superbugs: A Solution to the Antibiotics Crisis?

Viruses vs. Superbugs: A Solution to the Antibiotics Crisis?